Company intelligence / Profile preview

Slope

Norfolk, Virginia, United Statesslope-gang.com ↗

Ownership: Private
Development stage: Other

Overview

Slope provides an end-to-end digital platform for managing the biospecimen lifecycle in complex clinical trials. Its solutions enable real-time sample metadata capture, inventory management, chain-of-custody tracking, protocol adherence, and regulatory compliance. The company reports supporting over 13,000 studies with zero study delays due to sample loss and 100% sample integrity as of June 2023.

Therapeutic areas: Other
Modalities: Not applicable (Slope does not develop therapeutics; it provides software/services for clinical trial biospecimen and supply management)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

LumabridgeParker Institute for Cancer ImmunotherapyCyteir TherapeuticsHarbinger HealthProxima Clinical ResearchLabConnect

Beyond the preview

Go deeper on Slope.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Slope.

Explore the full profile